Time Out is CoreAge Rx’s prescription skincare offering built around estriol, vitamin C, and hydrolyzed hyaluronic acid. The public product page gives the strengths of those ingredients and advertises a starting price of $48 per month. That makes the formula identifiable, while leaving practical details to confirm during the prescribing and ordering process.

CoreAge Rx receives this journal’s sponsored first placement. This is a researched review of its public offer, not an account of using the cream, an independent pharmacy inspection, or a finding that it produces better clinical results than competitors. The useful question is what the published information lets you understand before you start a visit.

KEEP IN MIND

Time Out publishes a three-ingredient formula and a starting price. Confirm the complete prescription, supply, and refill terms before treating that headline as your final plan.

What is actually in the published formula?

CoreAge lists estriol 0.3%, vitamin C 5%, and hydrolyzed hyaluronic acid 0.5%. Record all three when discussing the product with a clinician. “Estriol cream” alone is an incomplete description of a combination preparation, and a matching estriol percentage does not make two finished products interchangeable.

Estriol is an estrogen, so this is more than a moisturizing cream with an appealing name. The other listed ingredients are part of the same prescription vehicle. Ask for the complete ingredient list, especially if you already know that a preservative, fragrance, or skincare ingredient bothers your skin. The public summary is a starting point for that discussion, not a replacement for the dispensing label.

The page describes goals related to the appearance of hydration, firmness, brightness, and texture. Those are the provider’s intended benefits. They do not tell you how much improvement an individual will see or whether a change comes from estriol, the other ingredients, the base, or a combination.

What does the starting price buy?

The verified offer says “starting at” $48 per month and advertises free delivery, no membership fees, and no long-term contracts. These are useful commercial statements, but the monthly figure is not a complete invoice. We did not verify a personalized checkout total or a fixed quantity for every prescription.

Before paying, establish the amount charged today, the quantity supplied, the expected refill interval, and how a refill is authorized. Ask whether the same price applies after the first order, how to stop an upcoming shipment, and what happens financially if the clinician decides the product is unsuitable. A clear answer should distinguish medication charges from any visit or other charge.

Our estriol cream comparison keeps competitors’ advertised supply periods attached to their prices. A one-month starting figure cannot be treated as the same offer as a fixed three-month purchase.

The consultation is part of the product decision

CoreAge describes an online health questionnaire, physician review, and delivery if a prescription is granted. Completing the questionnaire does not establish eligibility. The prescriber needs the information that could change the decision, including other hormone treatment, relevant diagnoses, skin problems, medicines, and pregnancy-related circumstances.

Be specific about the concern you hope to address. Dryness, a new rash, pigmentation, and loss of firmness are different complaints. A product page groups them for browsing, while a clinical consultation should decide whether they need different approaches. The menopause skincare guide helps organize those concerns without assuming every change needs a hormone cream.

Ask how to contact the clinical team if the skin becomes uncomfortable or a new symptom appears. Customer-service availability and access to a prescribing clinician are not necessarily the same service. Find out who handles a medical question and whether a follow-up assessment is included.

Ingredient research does not test this complete product

Historical studies have investigated topical estriol and other estrogens. They give a reason to investigate the subject, but they did not evaluate every contemporary combination sold online. We did not identify a randomized trial of the exact Time Out three-ingredient product in the materials reviewed.

That distinction matters even when an ingredient concentration resembles a published study. The vehicle, application instructions, participants, comparison treatment, and follow-up period all affect what can be inferred. Our research reading guide separates those layers.

Compounded drugs are not FDA-approved. FDA does not review each compounded product for safety, effectiveness, and quality before it is marketed. A clinician’s prescription and a stated ingredient list do not change that regulatory status.

Questions worth taking into the visit

  • What complete formula and quantity would be prescribed for me?
  • How does my medical history or existing hormone treatment affect the decision?
  • What change would count as a worthwhile result, and when would we reassess?
  • Which symptoms should lead me to stop using it and contact the clinical team?
  • What are the exact first-order, renewal, and cancellation terms?

Keep the answers with the prescription instructions. Do not borrow an application schedule from a review of another product or increase the amount to chase faster results. The safety guide explains why “topical” should not be read as a promise of no systemic exposure.

Time Out offers a clearly described combination to discuss with a prescriber. The unresolved details are the ones a good consultation and written order should settle: personal suitability, the dispensed product, realistic expectations, and the complete financial commitment.

THE NOTES BEHIND THIS CHAPTER

Sources & context

Public materials checked September 24, 2026. Product pages are commercial sources; study results apply to the tested conditions.

  1. CoreAge Rx — Time Out product page ↗

    Formula, advertised starting price, consultation steps, and product cautions. Commercial claims are not independent outcome evidence.

  2. FDA — Understanding the risks of compounded drugs ↗

    Compounded drugs are not FDA-approved; FDA does not review them for safety, effectiveness, or quality before marketing.

  3. FDA — Menopause: estriol and compounded hormones ↗

    No FDA-approved drugs contain estriol. FDA does not establish estriol as a safer form of estrogen. General hormone-therapy guidance is not a product-specific facial risk estimate.

  4. Schmidt et al. — Treatment of skin aging with topical estrogens (1996) ↗

    Compared estriol and estradiol preparations in 59 women over six months. Historical formulations and limited follow-up do not establish current-brand equivalence or long-term safety.